BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 22595609)

  • 1. Molecular pathways: targeting p21-activated kinase 1 signaling in cancer--opportunities, challenges, and limitations.
    Eswaran J; Li DQ; Shah A; Kumar R
    Clin Cancer Res; 2012 Jul; 18(14):3743-9. PubMed ID: 22595609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological significance and the associated signaling pathway of p21-activated kinase 1 (PAK1) in colorectal cancer.
    Pyo JS; Min KW; Oh IH; Lim DH; Son BK
    Pathol Res Pract; 2023 Nov; 251():154820. PubMed ID: 37801909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PAK1 and Therapy Resistance in Melanoma.
    Kichina JV; Maslov A; Kandel ES
    Cells; 2023 Sep; 12(19):. PubMed ID: 37830586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapamycin vs TORin-1 or Gleevec vs Nilotinib: Simple chemical evolution that converts PAK1-blockers to TOR-blockers or vice versa?
    Maruta H; He H
    Drug Discov Ther; 2024 Jun; 18(2):134-139. PubMed ID: 38569833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Computer-aided prediction and molecular mechanism investigation of active components in compound Kushen injection inhibiting p21-activated kinase 1].
    Lin L; Chang J; Tian Y; Chen J
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2024 Apr; 41(2):313-320. PubMed ID: 38686412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of p-21-activated kinases in cancer progression.
    King H; Nicholas NS; Wells CM
    Int Rev Cell Mol Biol; 2014; 309():347-87. PubMed ID: 24529727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PAK signaling in cancer.
    Ye DZ; Field J
    Cell Logist; 2012 Apr; 2(2):105-116. PubMed ID: 23162742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PAK signalling during the development and progression of cancer.
    Radu M; Semenova G; Kosoff R; Chernoff J
    Nat Rev Cancer; 2014 Jan; 14(1):13-25. PubMed ID: 24505617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signaling, Regulation, and Specificity of the Type II p21-activated Kinases.
    Ha BH; Morse EM; Turk BE; Boggon TJ
    J Biol Chem; 2015 May; 290(21):12975-83. PubMed ID: 25855792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel insights into mechanisms for Pak1-mediated regulation of cardiac Ca(2+) homeostasis.
    Wang Y; Tsui H; Bolton EL; Wang X; Huang CL; Solaro RJ; Ke Y; Lei M
    Front Physiol; 2015; 6():76. PubMed ID: 25852566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of MTA1 in head and neck cancers.
    Marzook H; Deivendran S; Kumar R; Pillai MR
    Cancer Metastasis Rev; 2014 Dec; 33(4):953-64. PubMed ID: 25359583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PAK1 tyrosine phosphorylation is required to induce epithelial-mesenchymal transition and radioresistance in lung cancer cells.
    Kim E; Youn H; Kwon T; Son B; Kang J; Yang HJ; Seong KM; Kim W; Youn B
    Cancer Res; 2014 Oct; 74(19):5520-31. PubMed ID: 25125660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p21-activated kinase inhibitors.
    Rudolph J; Crawford JJ; Hoeflich KP; Chernoff J
    Enzymes; 2013; 34 Pt. B():157-80. PubMed ID: 25034104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P21 activated kinases: structure, regulation, and functions.
    Rane CK; Minden A
    Small GTPases; 2014; 5():. PubMed ID: 24658305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytosolic functions of MORC2 in lipogenesis and adipogenesis.
    Sánchez-Solana B; Li DQ; Kumar R
    Biochim Biophys Acta; 2014 Feb; 1843(2):316-26. PubMed ID: 24286864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MTA1 promotes STAT3 transcription and pulmonary metastasis in breast cancer.
    Pakala SB; Rayala SK; Wang RA; Ohshiro K; Mudvari P; Reddy SD; Zheng Y; Pires R; Casimiro S; Pillai MR; Costa L; Kumar R
    Cancer Res; 2013 Jun; 73(12):3761-70. PubMed ID: 23580571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombin stimulation of inflammatory breast cancer cells leads to aggressiveness via the EGFR-PAR1-Pak1 pathway.
    Ohshiro K; Bui-Nguyen TM; Divijendra Natha RS; Schwartz AM; Levine P; Kumar R
    Int J Biol Markers; 2012 Dec; 27(4):e305-13. PubMed ID: 23280128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of PAK4 or PAK1 inhibits the proliferation of mutant KRAS colon cancer cells independently of RAF/MEK/ERK and PI3K/AKT signaling.
    Tabusa H; Brooks T; Massey AJ
    Mol Cancer Res; 2013 Feb; 11(2):109-21. PubMed ID: 23233484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metastasis-associated protein 1/histone deacetylase 4-nucleosome remodeling and deacetylase complex regulates phosphatase and tensin homolog gene expression and function.
    Reddy SD; Pakala SB; Molli PR; Sahni N; Karanam NK; Mudvari P; Kumar R
    J Biol Chem; 2012 Aug; 287(33):27843-50. PubMed ID: 22700976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P21 activated kinase signaling in cancer.
    Rane CK; Minden A
    Semin Cancer Biol; 2019 Feb; 54():40-49. PubMed ID: 29330094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.